Project Details
| Acronym | PQ-110-001 |
|---|---|
| Status | Active |
| Effective start/end date | 20/01/21 → 19/01/24 |
A Randomised, Double-Masked Vehicle-Controlled, Multiple Dose, Dose Escalation Study to Evaluate the Safety and Tolerability of EXN407 in Subjects with Centre Involved Diabetic Macular Oedema Secondary to Diabetes Mellitus
- Merani, Rohan (Primary Chief Investigator)
- Tan, Pearlyn (Clinical Trial Unit Staff)
- Chapman, Nicola (Clinical Trial Unit Staff)
Project: Research